News

A new study reveals that almost half of the population is unaware of the relation between climate change and its effect on infectious diseases.

Researchers have known for some time that the bacteria that causes TB uses our body’s cholesterol – a steroid – as a food source. Researchers are taking a closer look at how with the aim of improving therapeutics against TB.

Researchers have developed an optical toolbox to build microscopes for a few hundred euros that deliver high-resolution images comparable to commercial microscopes that cost up to a thousand times more.

A research team have investigated the effects of nanosilver, currently used in almost 450 products for its antibacterial properties.

Researchers have created the world's first bioactive plant-based nanocellulose hydrogel to support organoid growth for drug screening and disease modeling for numerous diseases including COVID-19 and cancer.

Australian researchers have discovered a protein that could protect the kidneys from "bystander" damage caused by cancer therapies.

Vision loss related to aging or inherited genetic disease is often caused by defects in the retinal pigment epithelium (RPE) in the eye. In a recent study, researchers used induced pluripotent stem cells (iPSCs) derived from the skin of healthy donors and of patients with retinitis pigmentosa to find drugs with the potential to enhance RPE phagocytosis.

Researchers have uncovered a previously unknown mechanism for pain control involving a newly identified group of cells in the spinal cord. This discovery offers a potential target for enhancing the therapeutic effect of drugs for chronic pain.

The publisher Springer Nature has shared its gold open-access (OA) options for Nature journals that will be introduced from January 2021. Whilst the initiative to move towards OA is positive news for its proponents, the considerable price tag attached is a worry.

New research has been published that investigates protocell compartments.